Photo from wikipedia
More than 60% of patients with lung cancer are diagnosed at advanced stages. The introduction of targeted therapies requires molecular diagnosis to guide treatment. The aim of this study was… Click to show full abstract
More than 60% of patients with lung cancer are diagnosed at advanced stages. The introduction of targeted therapies requires molecular diagnosis to guide treatment. The aim of this study was to evaluate the feasibility of performing mutational analysis with brushing specimens obtained by radial‐miniprobe endobronchial ultrasound (R‐EBUS) plus fluoroscopy‐guided bronchoscopy in patients with peripheral pulmonary adenocarcinoma.
Keywords:
fluoroscopy guided;
analysis;
guided bronchoscopy;
plus fluoroscopy;
cytology;
ebus plus
Journal Title: Cancer Cytopathology
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Cancer Cytopathology
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!